Results 11 to 20 of about 49,940 (198)

Long-term safety and effectiveness of etanercept in JIA: an 18-year experience from the BiKeR registry

open access: yesArthritis Research & Therapy, 2020
Background At present, etanercept represents the most commonly prescribed biologic agent for juvenile idiopathic arthritis (JIA) treatment. Children and adolescents with JIA are often treated with etanercept over long periods, sometimes even into ...
Giulia Armaroli   +12 more
doaj   +1 more source

Etanercept

open access: yesReactions Weekly, 2012
Hoofnagle JH.
europepmc   +2 more sources

Comparison of the inhibitory effect of tocilizumab and etanercept on the progression of joint erosion in rheumatoid arthritis treatment

open access: yesScientific Reports, 2022
We compared the efficacy of tocilizumab and etanercept in inhibiting radiographic progression of joint destruction in rheumatoid arthritis. Overall, 187 patients treated with etanercept or tocilizumab were selected.
Shinya Hayashi   +11 more
doaj   +1 more source

Intra-articular vs. systemic administration of etanercept in antigen-induced arthritis in the temporomandibular point. Part I: histological effects

open access: yesPediatric Rheumatology Online Journal, 2009
Background Temporomandibular joint (TMJ) arthritis in children causes alterations in craniomandibular growth. This abnormal growth may be prevented by an early anti-inflammatory intervention.
Nyengaard Jens R   +6 more
doaj   +1 more source

Etanercept alleviates psoriasis by reducing the Th17/Treg ratio and promoting M2 polarization of macrophages

open access: yesImmunity, Inflammation and Disease, 2022
Introduction This study aimed to investigate the effect of etanercept in psoriasis and its underlying mechanism. Methods Female mice were treated with imiquimod (IMQ) to induce psoriasis, and intraperitoneally administered etanercept (0.1–0.4 mg/ml). The
Xiaoqing Li   +3 more
doaj   +1 more source

Biologic TNF-α Inhibitors for Stevens–Johnson Syndrome, Toxic Epidermal Necrolysis, and TEN-SJS Overlap: A Study-Level and Patient-Level Meta-Analysis

open access: yesDermatology and Therapy, 2023
Introduction Stevens–Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) are severe cutaneous adverse reactions with high morbidity and mortality and not clearly established treatment protocol.
Jiali Cao   +3 more
doaj   +1 more source

Etanercept Attenuates Traumatic Brain Injury in Rats by Reducing Brain TNF-α Contents and by Stimulating Newly Formed Neurogenesis

open access: yesMediators of Inflammation, 2013
It remains unclear whether etanercept penetrates directly into the contused brain and improves the outcomes of TBI by attenuating brain contents of TNF-α and/or stimulating newly formed neurogenesis.
Chong-Un Cheong   +5 more
doaj   +1 more source

Paradoxical worsening of nontuberculous mycobacterial disease after the discontinuation of antitumor necrosis factor therapy: A case report

open access: yesRespiratory Medicine Case Reports, 2022
Antitumor necrosis factor–associated nontuberculous mycobacteria-immune reconstitution inflammatory syndrome (IRIS) has rarely been reported. An 84-year-old woman with a history of rheumatoid arthritis treated with etanercept was diagnosed with ...
Daijiro Nabeya, Tomoo Kishaba
doaj   +1 more source

AASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury

open access: yes, 2022
Hepatology, EarlyView.
Robert J. Fontana   +6 more
wiley   +1 more source

Etanercept ameliorate cardiac damage and Apoptosis Induced by Myocardial Ischemia/Reperfusion in male mice.

open access: yesKufa Journal for Veterinary Medical Sciences, 2014
Ischemia-reperfusion of cardiac tissues may lead to a prominent damage of the cardiomyocyte through either necrosis or apoptosis that seems to be the predominant modes of death during this period. In this study, we investigated the effects of Etanercept
Najah R. Hadi   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy